Discover open access scientific publications

Search, annotate, share and cite publications

Publications by K. Rulli

Tissue Distribution and Timing of Appearance of Polytropic Envelope Recombinants During Infection With SL3-3 Murine Leukemia Virus or Its Weakly Pathogenic SL3 Myb5 Mutant

Journal of Virology

English

Related publications

Increased Lymphomagenicity and Restored Disease Specificity of AML1 Site (Core) Mutant SL3-3 Murine Leukemia Virus by a Second-Site Enhancer Variant Evolved in Vivo.

English

Stability of AML1 (Core) Site Enhancer Mutations in T Lymphomas Induced by Attenuated SL3-3 Murine Leukemia Virus Mutants.

English

Analysis of Wild-Type and Mutant SL3-3 Murine Leukemia Virus Insertions in the C-Myc Promoter During Lymphomagenesis Reveals Target Site Hot Spots, Virus-Dependent Patterns, and Frequent Error-Prone Gap Repair

English

Increased Induction of Osteopetrosis, but Unaltered Lymphomagenicity, by Murine Leukemia Virus SL3-3 After Mutation of a Nuclear Factor 1 Site in the Enhancer

English

The Role of Envelope Glycoprotein Processing in Murine Leukemia Virus Infection.

English

Second-Site Proviral Enhancer Alterations in Lymphomas Induced by Enhancer Mutants of SL3-3 Murine Leukemia Virus: Negative Effect of Nuclear Factor 1 Binding Site.

English

Stoichiometry of Murine Leukemia Virus Envelope Protein-Mediated Fusion and Its Neutralization

English

Sl3–foam Homology Calculations

Algebraic and Geometric Topology

Geometry

Topology

2013

English

Sequence Tags of Provirus Integration Sites in DNAs of Tumors Induced by the Murine Retrovirus SL3-3.

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by K. Rulli

Tissue Distribution and Timing of Appearance of Polytropic Envelope Recombinants During Infection With SL3-3 Murine Leukemia Virus or Its Weakly Pathogenic SL3 Myb5 Mutant

Related publications

Increased Lymphomagenicity and Restored Disease Specificity of AML1 Site (Core) Mutant SL3-3 Murine Leukemia Virus by a Second-Site Enhancer Variant Evolved in Vivo.

Stability of AML1 (Core) Site Enhancer Mutations in T Lymphomas Induced by Attenuated SL3-3 Murine Leukemia Virus Mutants.

Analysis of Wild-Type and Mutant SL3-3 Murine Leukemia Virus Insertions in the C-Myc Promoter During Lymphomagenesis Reveals Target Site Hot Spots, Virus-Dependent Patterns, and Frequent Error-Prone Gap Repair

Increased Induction of Osteopetrosis, but Unaltered Lymphomagenicity, by Murine Leukemia Virus SL3-3 After Mutation of a Nuclear Factor 1 Site in the Enhancer

The Role of Envelope Glycoprotein Processing in Murine Leukemia Virus Infection.

Second-Site Proviral Enhancer Alterations in Lymphomas Induced by Enhancer Mutants of SL3-3 Murine Leukemia Virus: Negative Effect of Nuclear Factor 1 Binding Site.

Stoichiometry of Murine Leukemia Virus Envelope Protein-Mediated Fusion and Its Neutralization

Sl3–foam Homology Calculations

Sequence Tags of Provirus Integration Sites in DNAs of Tumors Induced by the Murine Retrovirus SL3-3.